Recent studies have demonstrated that increased proportion of tumor-infiltrating FoxP3+ Tregs predict a poor prognosis of patients with cancer, including breast [5], ovarian [6], hepatocellular [7] and gastric carcinomas [8]. The gene discussed is FOXP3; the disease is cancer.